TY - JOUR
T1 - YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation
AU - Kim, Jongshin
AU - Kim, Yoo Hyung
AU - Kim, Jaeryung
AU - Park, Do Young
AU - Bae, Hosung
AU - Lee, Da Hye
AU - Kim, Kyun Hoo
AU - Hong, Seon Pyo
AU - Jang, Seung Pil
AU - Kubota, Yoshiaki
AU - Kwon, Young Guen
AU - Lim, Dae Sik
AU - Koh, Gou Young
N1 - Funding Information:
We thank Sun-Hye Jeong and Wonyoung Choi for reagents and comments. We thank Intae Park for proofreading of the manuscript. We also thank Sujin Seo and Hyun Tae Kim for their technical assistance. This study was supported by the Institute for Basic Science funded by the Ministry of Science, ICT and Future Planning, Korea (IBS-R025-D1-2015 to GYK).
PY - 2017/9/1
Y1 - 2017/9/1
N2 - Angiogenesis is a multistep process that requires coordinated migration, proliferation, and junction formation of vascular endothelial cells (ECs) to form new vessel branches in response to growth stimuli. Major intracellular signaling pathways that regulate angiogenesis have been well elucidated, but key transcriptional regulators that mediate these signaling pathways and control EC behaviors are only beginning to be understood. Here, we show that YAP/TAZ, a transcriptional coactivator that acts as an end effector of Hippo signaling, is critical for sprouting angiogenesis and vascular barrier formation and maturation. In mice, endothelial-specific deletion of Yap/Taz led to blunted-end, aneurysm-like tip ECs with fewer and dysmorphic filopodia at the vascular front, a hyper-pruned vascular network, reduced and disarranged distributions of tight and adherens junction proteins, disrupted barrier integrity, subsequent hemorrhage in growing retina and brain vessels, and reduced pathological choroidal neovascularization. Mechanistically, YAP/TAZ activates actin cytoskeleton remodeling, an important component of filopodia formation and junction assembly. Moreover, YAP/TAZ coordinates EC proliferation and metabolic activity by upregulating MYC signaling. Overall, these results show that YAP/TAZ plays multifaceted roles for EC behaviors, proliferation, junction assembly, and metabolism in sprouting angiogenesis and barrier formation and maturation and could be a potential therapeutic target for treating neovascular diseases.
AB - Angiogenesis is a multistep process that requires coordinated migration, proliferation, and junction formation of vascular endothelial cells (ECs) to form new vessel branches in response to growth stimuli. Major intracellular signaling pathways that regulate angiogenesis have been well elucidated, but key transcriptional regulators that mediate these signaling pathways and control EC behaviors are only beginning to be understood. Here, we show that YAP/TAZ, a transcriptional coactivator that acts as an end effector of Hippo signaling, is critical for sprouting angiogenesis and vascular barrier formation and maturation. In mice, endothelial-specific deletion of Yap/Taz led to blunted-end, aneurysm-like tip ECs with fewer and dysmorphic filopodia at the vascular front, a hyper-pruned vascular network, reduced and disarranged distributions of tight and adherens junction proteins, disrupted barrier integrity, subsequent hemorrhage in growing retina and brain vessels, and reduced pathological choroidal neovascularization. Mechanistically, YAP/TAZ activates actin cytoskeleton remodeling, an important component of filopodia formation and junction assembly. Moreover, YAP/TAZ coordinates EC proliferation and metabolic activity by upregulating MYC signaling. Overall, these results show that YAP/TAZ plays multifaceted roles for EC behaviors, proliferation, junction assembly, and metabolism in sprouting angiogenesis and barrier formation and maturation and could be a potential therapeutic target for treating neovascular diseases.
UR - http://www.scopus.com/inward/record.url?scp=85028950321&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85028950321&partnerID=8YFLogxK
U2 - 10.1172/JCI93825
DO - 10.1172/JCI93825
M3 - Article
C2 - 28805663
AN - SCOPUS:85028950321
SN - 0021-9738
VL - 127
SP - 3441
EP - 3461
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 9
ER -